XML 23 R4.htm IDEA: XBRL DOCUMENT v3.22.0.1
CONSOLIDATED STATEMENTS OF EARNINGS AND COMPREHENSIVE INCOME
$ in Thousands, € in Millions, ৳ in Millions, ¥ in Millions, ¥ in Millions, £ in Millions, $ in Millions, $ in Millions, $ in Millions, $ in Millions
 12 Months Ended
Jan. 02, 2022
USD ($)
$ / shares
Jan. 03, 2021
USD ($)
$ / shares
Profit or loss [abstract]    
Net sales (note 27) $ 2,922,570 $ 1,981,276
Cost of sales (note 17(c)) 1,982,361 1,732,217
Gross profit 940,209 249,059
Selling, general and administrative expenses (note 17(a)) 314,171 272,306
Reversal of impairment (Impairment) of trade accounts receivable (2,617) 15,453
Restructuring and acquisition-related costs (note 18) 8,225 48,154
(Impairment reversal, net of write-downs) (31,459) 93,989
Operating income (loss) 651,889 (180,843)
Financial expenses, net (note 15(c)) 27,331 48,530
Earnings (loss) before income taxes 624,558 (229,373)
Income tax expense (recovery) (note 19) 17,375 (4,091)
Net earnings (loss) 607,183 (225,282)
Other comprehensive income (loss), net of related income taxes:    
Cash flow hedges (note 15(d)) 73,847 (8,503)
Actuarial (loss) gain on employee benefit obligations (note 13(a)) (21,678) 12,142
Other comprehensive income 52,169 3,639
Comprehensive income (loss) $ 659,352 $ (221,643)
Earnings (loss) per share (note 20):    
Basic (in dollars per share) | $ / shares $ 3.08 $ (1.14)
Diluted (in dollars per share) | $ / shares $ 3.07 $ (1.14)